Company: INVUP
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022223
Chunk: 93

Company: Investview, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 93
---
 a net $10,002 reduction in stock-based compensation based on grant
date fair values and vesting terms of awards granted in prior periods.

As
of September 30, 2025 and December 31, 2024, we had 1,859,231,786 and 1,859,231,786 shares of common stock issued and 1,850,730,283 and
1,859,231,786 shares of common stock outstanding, respectively.

    22

INVESTVIEW,
INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2025

(Unaudited)

Options

The
2022 Incentive Plan authorizes a variety of incentive awards consisting of stock options, restricted stock, restricted stock units, and
reserves for issuance up to 600,000,000 shares of the Company’s common stock.

Transactions
involving our options are summarized as follows:

SCHEDULE OF OPTIONS ACTIVITY 

    Weighted 

    Average 

    Weighted  
    Grant-Date 

    Number of  
    Average  
    Per Share 

    Options  
    Exercise Price  
    Fair Value 
  
    Options outstanding at December 31, 2024 
     351,416,665  
    $0.05  
    $0.03 
  
    Granted 
     -  
    $-  
    $- 
  
    Canceled/Expired 
     -  
    $-  
    $- 
  
    Exercised 
     -  
    $-  
    $- 
  
    Options outstanding at September 30, 2025 
     351,416,665  
    $0.05  
    $0.03 

Details
of our options outstanding as of September 30, 2025, are as follows:

SCHEDULE OF OPTIONS OUTSTANDING 

    Options Exercisable  
    Weighted Average
 Exercise Price of Options
 Exercisable  
    Weighted Average
 Contractual Life of Options
 Exercisable (Years)  
    Weighted Average
 Contractual Life of Options
 Outstanding (Years) 
  
     236,741,665  
    $0.05  
     3.76  
     3.88 

Total
stock compensation expense related to